{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:30:15Z","timestamp":1785310215572,"version":"3.55.0"},"reference-count":275,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["GA KK01.1.1.01.0007"],"award-info":[{"award-number":["GA KK01.1.1.01.0007"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00702-021-02457-2","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T10:08:03Z","timestamp":1641290883000},"page":"773-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Challenges of repurposing tetracyclines for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease"],"prefix":"10.1007","volume":"129","author":[{"given":"Iva","family":"Markulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Matasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktorija Erdeljic","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-7142","authenticated-orcid":false,"given":"Melita","family":"Salkovi\u0107-Petrisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"1\u20133","key":"2457_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbamcr.2004.09.006","volume":"1742","author":"AY Abramov","year":"2004","unstructured":"Abramov AY, Canevari L, Duchen MR (2004) Calcium signals induced by amyloid \u03b2 peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742(1\u20133):81\u201387. https:\/\/doi.org\/10.1016\/j.bbamcr.2004.09.006","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2457_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh KN, MacGowan A (2006) Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58(2):256\u2013265. https:\/\/doi.org\/10.1093\/jac\/dkl224","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2457_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-017-0379-z","volume":"24","author":"W Ahmad","year":"2017","unstructured":"Ahmad W, Ijaz B, Shabbiri K, Ahmed F, Rehman S (2017) Oxidative toxicity in diabetes and Alzheimer\u2019s disease: mechanisms behind ROS\/RNS generation. J Biomed Sci 24(1):76. https:\/\/doi.org\/10.1186\/s12929-017-0379-z","journal-title":"J Biomed Sci"},{"issue":"2","key":"2457_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1039\/c0ob00303d","volume":"9","author":"C Airoldi","year":"2011","unstructured":"Airoldi C, Colombo L, Manzoni C et al (2011) Tetracycline prevents A\u03b2 oligomer toxicity through an atypical supramolecular interaction. Org Biomol Chem 9(2):463\u2013472. https:\/\/doi.org\/10.1039\/c0ob00303d","journal-title":"Org Biomol Chem"},{"key":"2457_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fendo.2015.00013","volume":"6","author":"AA Akintola","year":"2015","unstructured":"Akintola AA, van Heemst D (2015) Insulin, aging, and the brain: mechanisms and implications. Front Endocrinol (lausanne) 6:13. https:\/\/doi.org\/10.3389\/fendo.2015.00013","journal-title":"Front Endocrinol (lausanne)"},{"issue":"3","key":"2457_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Alzheimer\u2019s Association","year":"2019","unstructured":"Alzheimer\u2019s Association (2019) 2019 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dementia 15(3):321\u2013387. https:\/\/doi.org\/10.1016\/j.jalz.2019.01.010","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"4","key":"2457_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00213-018-5137-8","volume":"236","author":"M Amani","year":"2019","unstructured":"Amani M, Shokouhi G, Salari AA (2019) Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer\u2019s disease. Psychopharmacology 236(4):1281\u20131292. https:\/\/doi.org\/10.1007\/s00213-018-5137-8","journal-title":"Psychopharmacology"},{"issue":"24","key":"2457_CR11","doi-asserted-by":"publisher","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","volume":"93","author":"AR Amin","year":"1996","unstructured":"Amin AR, Attur MG, Thakker GD et al (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 93(24):14014\u201314019. https:\/\/doi.org\/10.1073\/pnas.93.24.14014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2\u20133","key":"2457_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-5793(97)00605-4","volume":"410","author":"AR Amin","year":"1997","unstructured":"Amin AR, Pattel RN, Thakker GD et al (1997) Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 410(2\u20133):259\u2013264. https:\/\/doi.org\/10.1016\/S0014-5793(97)00605-4","journal-title":"FEBS Lett"},{"issue":"1","key":"2457_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1494-4","volume":"16","author":"F Angelucci","year":"2019","unstructured":"Angelucci F, Cechova K, Amlerova J et al (2019) Antibiotics, gut microbiota, and Alzheimer\u2019s disease. J Neuroinflammation 16(1):1\u201310. https:\/\/doi.org\/10.1186\/s12974-019-1494-4","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2457_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10863-010-9271-1","volume":"42","author":"YN Antonenko","year":"2010","unstructured":"Antonenko YN, Rokitskaya TI, Cooper AJL et al (2010) Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels. J Bioenerg Biomembr 42(2):151\u2013163. https:\/\/doi.org\/10.1007\/s10863-010-9271-1","journal-title":"J Bioenerg Biomembr"},{"key":"2457_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345791","volume":"35","author":"BS Appleby","year":"2013","unstructured":"Appleby BS, Nacopoulos D, Milano N et al (2013) A review: treatment of Alzheimer\u2019s disease discovered in repurposed agents. Dement Geriatr Cogn Disord 35:1\u201322. https:\/\/doi.org\/10.1159\/000345791","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"2457_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today 21(5):802\u2013818. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.013","journal-title":"Drug Discov Today"},{"issue":"7","key":"2457_CR17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00415-018-8768-0","volume":"265","author":"KI Avgerinos","year":"2018","unstructured":"Avgerinos KI, Kalaitzdis G, Malli A et al (2018) Intranasal insulin in Alzheimer\u2019s dementia or mild cognitive impairment: a systematic review. J Neurol 265(7):1497\u20131510. https:\/\/doi.org\/10.1007\/s00415-018-8768-0","journal-title":"J Neurol"},{"issue":"5","key":"2457_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12551-017-0317-z","volume":"9","author":"CL Avila","year":"2017","unstructured":"Avila CL, Chaves S, Socias SB et al (2017) Lessons learned from protein aggregation: toward technological and biomedical applications. Biophys Rev 9(5):501\u2013515. https:\/\/doi.org\/10.1007\/s12551-017-0317-z","journal-title":"Biophys Rev"},{"issue":"9","key":"2457_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.325","volume":"4","author":"EP Azevedo","year":"2013","unstructured":"Azevedo EP, Ledo JH, Barbosa G et al (2013) Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis. Cell Death Dis 4(9):e789. https:\/\/doi.org\/10.1038\/cddis.2013.325","journal-title":"Cell Death Dis"},{"issue":"1","key":"2457_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/138955712798868977","volume":"12","author":"F Bahrami","year":"2011","unstructured":"Bahrami F, Morris DL, Pourgholami MH (2011) Tetracyclines: drugs with huge therapeutic potential. Mini Rev Med Chem 12(1):44\u201352. https:\/\/doi.org\/10.2174\/138955712798868977","journal-title":"Mini Rev Med Chem"},{"key":"2457_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fphar.2019.00738","volume":"10","author":"C Balducci","year":"2019","unstructured":"Balducci C, Forloni G (2019) Doxycycline for Alzheimer\u2019s disease: fighting \u03b2-amyloid oligomers and neuroinflammation. Front Pharmacol 10:738. https:\/\/doi.org\/10.3389\/fphar.2019.00738","journal-title":"Front Pharmacol"},{"key":"2457_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","volume":"70","author":"C Balducci","year":"2018","unstructured":"Balducci C, Santamaria G, La Vitola P et al (2018) Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models. Neurobiol Aging 70:128\u2013139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.002","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2457_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA (2012) Insulin in the brain: there and back again. Pharmacol Ther 136(1):82\u201393. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.006","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2457_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00702-020-02152-8","volume":"127","author":"JO Barilar","year":"2020","unstructured":"Barilar JO, Knezovic A, Babic Perhoc A et al (2020) Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer\u2019s and Parkinson\u2019s disease. J Neural Transm (vienna) 127(2):231\u2013250. https:\/\/doi.org\/10.1007\/s00702-020-02152-8","journal-title":"J Neural Transm (vienna)"},{"key":"2457_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuroscience.2015.03.007","volume":"309","author":"RM Barrientos","year":"2015","unstructured":"Barrientos RM, Kitt MM, Watkins LR et al (2015) Neuroinflammation in the normal aging hippocampus. Neuroscience 309:84\u201399. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.03.007","journal-title":"Neuroscience"},{"issue":"4","key":"2457_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/01.idc.0000130890.12611.f3","volume":"12","author":"JG Bartlett","year":"2004","unstructured":"Bartlett JG (2004) Antibiotic use in relation to the risk of breast cancer. Infect Dis Clin Pract 12(4):263. https:\/\/doi.org\/10.1097\/01.idc.0000130890.12611.f3","journal-title":"Infect Dis Clin Pract"},{"key":"2457_CR27","first-page":"815","volume-title":"Basic and clinical pharmacology","author":"CEWL Beauduy","year":"2018","unstructured":"Beauduy CEWL (2018) Tetracyclines, macrolides, clindamycin, chloramphenicol, streptogramins, & oxazolidinones. In: Katzung BG (ed) Basic and clinical pharmacology, 14th edn. McGraw Hill-Education, New York, pp 815\u2013825","edition":"14"},{"issue":"4","key":"2457_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40257-017-0267-z","volume":"18","author":"A Beinenfeld","year":"2017","unstructured":"Beinenfeld A, Nagler AR, Orlow SJ (2017) Oral antibacterial therapy for Acne vulgaris: an evidence-based review. Am J Clin Dermatol 18(4):469\u2013490. https:\/\/doi.org\/10.1007\/s40257-017-0267-z","journal-title":"Am J Clin Dermatol"},{"issue":"13","key":"2457_CR29","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s41386-020-00811-8","volume":"45","author":"SC BerenS","year":"2020","unstructured":"BerenS SC, Bird CM, Harrison NA (2020) Minocycline differentially modulates human spatial memory systems. Neuropsychopharmacology 45(13):2162\u20132169. https:\/\/doi.org\/10.1038\/s41386-020-00811-8","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"2457_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000330363","volume":"9","author":"B Biscaro","year":"2012","unstructured":"Biscaro B, Lindvall O, Tesco G et al (2012) Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer\u2019s disease. Neurodegener Dis 9(4):187\u2013198. https:\/\/doi.org\/10.1159\/000330363","journal-title":"Neurodegener Dis"},{"issue":"1","key":"2457_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00614205","volume":"30","author":"R B\u00f6cker","year":"1986","unstructured":"B\u00f6cker R, M\u00fchlberg W, Platt D et al (1986) Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients. Eur J Clin Pharmacol 30(1):105\u2013108. https:\/\/doi.org\/10.1007\/BF00614205","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2457_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","volume":"19","author":"RM Bonelli","year":"2004","unstructured":"Bonelli RM, H\u00f6dl AK, Hofmann P et al (2004) Neuroprotection in Huntington\u2019s disease\u202f: a 2-year study on minocycline. Int Clin Psychopharmacol 19(6):337\u2013342. https:\/\/doi.org\/10.1097\/00004850-200411000-00004","journal-title":"Int Clin Psychopharmacol"},{"issue":"10","key":"2457_CR33","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","volume":"125","author":"M Bortolanza","year":"2018","unstructured":"Bortolanza M, Nascimento GC, Socias SB et al (2018) Tetracycline repurposing in neurodegeneration: focus on Parkinson\u2019s disease. J Neural Transm (vienna) 125(10):1403\u20131415. https:\/\/doi.org\/10.1007\/s00702-018-1913-1","journal-title":"J Neural Transm (vienna)"},{"issue":"13","key":"2457_CR34","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/bph.15439","volume":"178","author":"M Bortolanza","year":"2021","unstructured":"Bortolanza M, Nascimento GC, Raisman-Vozari R et al (2021) Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats. Br J Pharmacol 178(13):2595\u20132616. https:\/\/doi.org\/10.1111\/bph.15439","journal-title":"Br J Pharmacol"},{"issue":"10","key":"2457_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman MA, Lovell MA (2013) Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech Ageing Dev 134(10):486\u2013495. https:\/\/doi.org\/10.1016\/j.mad.2013.08.005","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"2457_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Comadiere B, Prigent A et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"J Clin Invest"},{"issue":"5","key":"2457_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1042\/BST0351119","volume":"35","author":"GC Brown","year":"2007","unstructured":"Brown GC (2007) Mechanisms of inflammatory neurodegeneration: INOS and NADPH oxidase. Biochem Soc Trans 35(5):1119\u20131121. https:\/\/doi.org\/10.1042\/BST0351119","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"2457_CR38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3233\/JAD-170543","volume":"62","author":"AD Butterfield","year":"2018","unstructured":"Butterfield AD, Boyd-Kimball D (2018) Oxidative stress, amyloid-\u03b2 peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer\u2019s disease. J Alzheimers Dis 62(3):1345\u20131367. https:\/\/doi.org\/10.3233\/JAD-170543","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2457_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/156720512799015064","volume":"9","author":"H Cai","year":"2012","unstructured":"Cai H, Cong W, Ji S et al (2012) Metabolic dysfunction in Alzheimers disease and related neurodegenerative disorders. Curr Alzheimer Res 9(1):5\u201317. https:\/\/doi.org\/10.2174\/156720512799015064","journal-title":"Curr Alzheimer Res"},{"key":"2457_CR40","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/CIA.S46536","volume":"8","author":"Z Cai","year":"2013","unstructured":"Cai Z, Yan Y, Wang Y (2013) Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Clin Interv Aging 8:1089\u20131095. https:\/\/doi.org\/10.2147\/CIA.S46536","journal-title":"Clin Interv Aging"},{"issue":"6","key":"2457_CR41","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12(6):719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"key":"2457_CR42","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212553","volume":"8","author":"S Cankaya","year":"2019","unstructured":"Cankaya S, Cankaya B, Kilic U et al (2019) The therapeutic role of minocycline in Parkinson\u2019s disease. Drugs Context 8:212553. https:\/\/doi.org\/10.7573\/dic.212553","journal-title":"Drugs Context"},{"issue":"8","key":"2457_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1096\/fj.02-0764com","volume":"17","author":"I Cardoso","year":"2003","unstructured":"Cardoso I, Merlini G, Saraiva MJ (2003) 4\u2032-Iodo-4\u2032-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. FASEB J 17(8):803\u2013809. https:\/\/doi.org\/10.1096\/fj.02-0764com","journal-title":"FASEB J"},{"issue":"10","key":"2457_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21100","volume":"21","author":"JR Chalmers","year":"2017","unstructured":"Chalmers JR, Wojnarowska F, Kirtsching G et al (2017) A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg\/day) with that of oral prednisolone (0.5 mg\/kg\/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial. Health Technol Assess 21(10):1\u201390. https:\/\/doi.org\/10.3310\/hta21100","journal-title":"Health Technol Assess"},{"key":"2457_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D et al (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464. https:\/\/doi.org\/10.1016\/j.redox.2017.10.014","journal-title":"Redox Biol"},{"issue":"7","key":"2457_CR46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/77528","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M et al (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6(7):797\u2013801","journal-title":"Nat Med"},{"issue":"8","key":"2457_CR47","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3109\/10715762.2012.674640","volume":"46","author":"S Chen","year":"2012","unstructured":"Chen S, Yin JH, Hwang CH et al (2012) Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase\/ceramide neurotoxicity: implication in Alzheimer\u2019s disease and cerebral ischemia. Free Radic Res 46(8):940\u2013950. https:\/\/doi.org\/10.3109\/10715762.2012.674640","journal-title":"Free Radic Res"},{"issue":"4","key":"2457_CR48","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 13(4):3391\u20133396. https:\/\/doi.org\/10.3892\/mmr.2016.4948","journal-title":"Mol Med Rep"},{"issue":"3","key":"2457_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","volume":"11","author":"G Ch\u00eane","year":"2015","unstructured":"Ch\u00eane G, Beiser A, Au R et al (2015) Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement 11(3):310\u2013320. https:\/\/doi.org\/10.1016\/j.jalz.2013.10.005","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2457_CR50","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/sj.npp.1301377","volume":"32","author":"Y Choi","year":"2007","unstructured":"Choi Y, Kim HS, Shin KY et al (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer\u2019s disease models. Neuropsychopharmacology 32(11):2393\u20132404. https:\/\/doi.org\/10.1038\/sj.npp.1301377","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2457_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jac\/29.3.245","volume":"29","author":"I Chopra","year":"1992","unstructured":"Chopra I, Hawkey PM, Hinton M (1992) Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother 29(3):245\u2013277. https:\/\/doi.org\/10.1093\/jac\/29.3.245","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"2457_CR52","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nrn4020","volume":"16","author":"HM Chow","year":"2015","unstructured":"Chow HM, Herrup K (2015) Genomic integrity and the ageing brain. Nat Rev Neurosci 16(11):672\u2013684. https:\/\/doi.org\/10.1038\/nrn4020","journal-title":"Nat Rev Neurosci"},{"key":"2457_CR53","doi-asserted-by":"publisher","first-page":"16027","DOI":"10.1038\/mtm.2016.27","volume":"5","author":"A Chtarto","year":"2016","unstructured":"Chtarto A, Humbert-Claude M, Bockstael O et al (2016) A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Mol Ther Methods Clin Dev 5:16027. https:\/\/doi.org\/10.1038\/mtm.2016.27","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10","key":"2457_CR54","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/jps.2600581003","volume":"58","author":"JL Colaizzi","year":"1969","unstructured":"Colaizzi JL, Klink PR (1969) pH-partition behavior of tetracyclines. J Pharm Sci 58(10):1184\u20131189. https:\/\/doi.org\/10.1002\/jps.2600581003","journal-title":"J Pharm Sci"},{"issue":"48","key":"2457_CR55","doi-asserted-by":"publisher","first-page":"41647","DOI":"10.1074\/jbc.M111.274548","volume":"286","author":"R Costa","year":"2011","unstructured":"Costa R, Speretta E, Crowther D et al (2011) Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease. J Biol Chem 286(48):41647\u201341655. https:\/\/doi.org\/10.1074\/jbc.M111.274548","journal-title":"J Biol Chem"},{"issue":"3","key":"2457_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","volume":"3","author":"S Craft","year":"2004","unstructured":"Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3(3):169\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(04)00681-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"2457_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.50.1.164","volume":"50","author":"S Craft","year":"1998","unstructured":"Craft S, Peskind E, Schwartz, MW et al (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50(1):164\u2013168. https:\/\/doi.org\/10.1212\/WNL.50.1.164","journal-title":"Neurology"},{"issue":"4","key":"2457_CR58","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM et al (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"issue":"1\u20133","key":"2457_CR59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000285514","volume":"7","author":"AC Cuello","year":"2010","unstructured":"Cuello AC, Ferretti MT, Leon WC et al (2010) Early-stage inflammation and experimental therapy in transgenic models of the Alzheimer-like amyloid pathology. Neurodegener Dis 7(1\u20133):96\u201398. https:\/\/doi.org\/10.1159\/000285514","journal-title":"Neurodegener Dis"},{"issue":"1 Suppl","key":"2457_CR60","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","volume":"10","author":"FG De Felice","year":"2014","unstructured":"De Felice FG, Lourenco MV, Ferreira ST (2014) How does brain insulin resistance develop in Alzheimer\u2019s disease? Alzheimers Dement 10(1 Suppl):S26\u2013S32. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.004","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2457_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","volume":"77","author":"SM De La Monte","year":"2017","unstructured":"De La Monte SM (2017) Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer\u2019s disease. Drugs 77(1):47\u201365. https:\/\/doi.org\/10.1007\/s40265-016-0674-0","journal-title":"Drugs"},{"issue":"4","key":"2457_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SMM De La MonteTong","year":"2014","unstructured":"De La MonteTong SMM (2014) Brain metabolic dysfunction at the core of Alzheimer\u2019s disease. Biochem Pharmacol 88(4):548\u2013559. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.012","journal-title":"Biochem Pharmacol"},{"key":"2457_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/329418","volume":"2015","author":"R Di Caprio","year":"2015","unstructured":"Di Caprio R, Lembo S, Di Costanzo L et al (2015) Anti-inflammatory properties of low and high doxycycline doses: an in vitro study. Mediators Inflamm 2015:329418. https:\/\/doi.org\/10.1155\/2015\/329418","journal-title":"Mediators Inflamm"},{"issue":"12","key":"2457_CR64","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","volume":"19","author":"E Diguet","year":"2004","unstructured":"Diguet E, Fernagut PO, Wei X et al (2004) Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease. Eur J Neurosci 19(12):3266\u20133276. https:\/\/doi.org\/10.1111\/j.0953-816X.2004.03372.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"2457_CR65","doi-asserted-by":"publisher","first-page":"a033878","DOI":"10.1101\/cshperspect.a033878","volume":"12","author":"CM Dobson","year":"2020","unstructured":"Dobson CM, Knowles TPJ, Vendruscolo M (2020) The amyloid phenomenon and its significance in biology and medicine. Cold Spring Harb Perspect Biol 12(2):a033878. https:\/\/doi.org\/10.1101\/cshperspect.a033878","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2457_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mds.22732","volume":"25","author":"R Dodel","year":"2010","unstructured":"Dodel R, Spottke A, Gerhard A et al (2010) Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial). Mov Disord 25(1):97\u2013107. https:\/\/doi.org\/10.1002\/mds.22732","journal-title":"Mov Disord"},{"key":"2457_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105256","volume":"151","author":"A Dominguez-Meijide","year":"2021","unstructured":"Dominguez-Meijide A, Parrales V, Vasili E et al (2021) Doxycycline inhibits \u03b1-synuclein-associated pathologies in vitro and in vivo. Neurobiol Dis 151:105256. https:\/\/doi.org\/10.1016\/j.nbd.2021.105256","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"2457_CR68","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"R Dorsey","year":"2018","unstructured":"Dorsey R, Sherer T, Okun MS (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(Suppl 1):S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"2457_CR69","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1128\/AAC.33.7.1078","volume":"33","author":"L Dotevall","year":"1989","unstructured":"Dotevall L, Hagberg L (1989) Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected lyme neuroborreliosis. Antimicrob Agents Chemother 33(7):1078\u20131080. https:\/\/doi.org\/10.1128\/AAC.33.7.1078","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2457_CR70","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1086\/515145","volume":"28","author":"L Dotevall","year":"1999","unstructured":"Dotevall L, Hagberg L (1999) Successful oral doxycycline treatment of lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28(3):569\u2013574. https:\/\/doi.org\/10.1086\/515145","journal-title":"Clin Infect Dis"},{"issue":"25","key":"2457_CR71","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S et al (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 98(25):14669\u201314674. https:\/\/doi.org\/10.1073\/pnas.251341998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2457_CR72","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9(7):a028035. https:\/\/doi.org\/10.1101\/cshperspect.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"2457_CR73","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","volume":"73","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Hansen PR, Gislason GH et al (2016) Exploring the association between Rosacea and Parkinson disease: a Danish Nationwide Cohort Study. JAMA Neurol 73(5):529\u2013534. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0022","journal-title":"JAMA Neurol"},{"issue":"1","key":"2457_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurol.2015.09.012","volume":"1580","author":"A Elbaz","year":"2015","unstructured":"Elbaz A, Carcaillon L, Kab S et al (2015) Epidemiology of Parkinson \u2019 s disease. Rev Neurol (paris) 1580(1):1\u201313. https:\/\/doi.org\/10.1016\/j.neurol.2015.09.012","journal-title":"Rev Neurol (paris)"},{"issue":"4","key":"2457_CR75","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1592\/phco.26.4.515","volume":"26","author":"HF Elewa","year":"2006","unstructured":"Elewa HF, Hilali H, Hess DC et al (2006) Minocycline for short-term neuroprotection. Pharmacotherapy 26(4):515\u2013521","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2457_CR76","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495\u2013516. https:\/\/doi.org\/10.1080\/01926230701320337","journal-title":"Toxicol Pathol"},{"key":"2457_CR77","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects, chapter 4","author":"NS Erekat","year":"2018","unstructured":"Erekat NS (2018) Apoptosis and its role in Parkinson\u2019s disease. In: Stoker TB, Greenland JC (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects, chapter 4. Codon Publications, Brisbane"},{"issue":"6","key":"2457_CR78","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1023\/B:JOCI.0000010420.96419.a8","volume":"23","author":"DW Ethell","year":"2003","unstructured":"Ethell DW, Buhler LA (2003) Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol 23(6):439\u2013446. https:\/\/doi.org\/10.1023\/B:JOCI.0000010420.96419.a8","journal-title":"J Clin Immunol"},{"issue":"3","key":"2457_CR79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/glia.20268","volume":"53","author":"A Familian","year":"2006","unstructured":"Familian A, Boshuizen RS, Eikelenboom P et al (2006) Inhibitory effect of minocycline on amyloid \u03b2 fibril formation and human microglial activation. Glia 53(3):233\u2013240. https:\/\/doi.org\/10.1002\/glia.20268","journal-title":"Glia"},{"issue":"12","key":"2457_CR80","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1523\/JNEUROSCI.4371-06.2007","volume":"27","author":"R Fan","year":"2007","unstructured":"Fan R, Xu F, Previti ML et al (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 27(12):3057\u20133063. https:\/\/doi.org\/10.1523\/JNEUROSCI.4371-06.2007","journal-title":"J Neurosci"},{"key":"2457_CR81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1742-2094-9-62","volume":"9","author":"MT Ferretti","year":"2012","unstructured":"Ferretti MT, Allard S, Partridge V et al (2012) Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology. J Neuroinflammation 9:62. https:\/\/doi.org\/10.1186\/1742-2094-9-62","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2457_CR82","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","volume":"487","author":"G Forloni","year":"2001","unstructured":"Forloni G, Colombo L, Girola L et al (2001) Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett 487(3):404\u2013407. https:\/\/doi.org\/10.1016\/S0014-5793(00)02380-2","journal-title":"FEBS Lett"},{"issue":"5","key":"2457_CR83","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0197-4580(02)00076-3","volume":"23","author":"G Forloni","year":"2002","unstructured":"Forloni G, Terreni L, Bertani I et al (2002) Protein misfolding in Alzheimer\u2019s and Parkinson\u2019s disease: genetics and molecular mechanisms. Neurobiol Aging 23(5):957\u2013976. https:\/\/doi.org\/10.1016\/S0197-4580(02)00076-3","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2457_CR84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1871526510909010023","volume":"9","author":"G Forloni","year":"2009","unstructured":"Forloni G, Salmona M, Marcon G (2009) Tetracyclines and prion infectivity. Infect Disord Drug Targets 9(1):23\u201330. https:\/\/doi.org\/10.2174\/1871526510909010023","journal-title":"Infect Disord Drug Targets"},{"issue":"1","key":"2457_CR85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1871526510909010023","volume":"9","author":"G Forloni","year":"2012","unstructured":"Forloni G, Salmona M, Marcon G et al (2012) Tetracyclines and prion infectivity. Infect Disord Drug Targets 9(1):23\u201330. https:\/\/doi.org\/10.2174\/1871526510909010023","journal-title":"Infect Disord Drug Targets"},{"issue":"2","key":"2457_CR86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/19336896.2015.1027857","volume":"9","author":"G Forloni","year":"2015","unstructured":"Forloni G, Tettamanti M, Lucca U et al (2015) Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases. Prion 9(2):75\u201379. https:\/\/doi.org\/10.1080\/19336896.2015.1027857","journal-title":"Prion"},{"key":"2457_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2019.04.019","volume":"44","author":"G Forloni","year":"2019","unstructured":"Forloni G, Roiter I, Tagliavini F (2019) Clinical trials of prion disease therapeutics. Curr Opin Pharmacol 44:53\u201360. https:\/\/doi.org\/10.1016\/j.coph.2019.04.019","journal-title":"Curr Opin Pharmacol"},{"key":"2457_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.pmbts.2020.11.001","volume":"177","author":"G Forloni","year":"2021","unstructured":"Forloni G, La Vitola P, Cerovic M et al (2021) Inflammation and Parkinson\u2019s disease pathogenesis: mechanisms and therapeutic insight. Prog Mol Biol Transl Sci 177:175\u2013202. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.11.001","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"11","key":"2457_CR89","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1158\/1055-9965.EPI-06-0401","volume":"15","author":"GD Friedman","year":"2006","unstructured":"Friedman GD, Oestreicher N, Chan J et al (2006) Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomarkers Prev 15(11):2102\u20132106. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0401","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4\u20135","key":"2457_CR90","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Fr\u00f6lich","year":"1998","unstructured":"Fr\u00f6lich L, Blum-Degen D, Bernstein HG et al (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease. J Neural Transm (vienna) 105(4\u20135):423\u2013438. https:\/\/doi.org\/10.1007\/s007020050068","journal-title":"J Neural Transm (vienna)"},{"key":"2457_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics1010001","volume":"1","author":"D Fuoco","year":"2012","unstructured":"Fuoco D (2012) Classification framework and chemical biology of tetracycline-structure-based drugs. Antibiotics 1:1\u201313. https:\/\/doi.org\/10.3390\/antibiotics1010001","journal-title":"Antibiotics"},{"issue":"1","key":"2457_CR92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/bmm.09.89","volume":"4","author":"D Galasko","year":"2010","unstructured":"Galasko D, Montine TJ (2010) Biomarkers of oxidative damage and inflammation in Alzheimers disease. Biomark Med 4(1):27\u201336. https:\/\/doi.org\/10.2217\/bmm.09.89","journal-title":"Biomark Med"},{"key":"2457_CR93","doi-asserted-by":"publisher","first-page":"428010","DOI":"10.1155\/2012\/428010","volume":"2012","author":"S Gandhi","year":"2012","unstructured":"Gandhi S, Abramov AY (2012) Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012:428010. https:\/\/doi.org\/10.1155\/2012\/428010","journal-title":"Oxid Med Cell Longev"},{"key":"2457_CR94","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnpbp.2017.03.010","volume":"77","author":"ML Garcez","year":"2017","unstructured":"Garcez ML, Mina F, Bellettini-Santos T et al (2017) Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid \u03b2 (1\u201342) in mice. Prog Neuropsychopharmacol Biol Psychiatry 77:23\u201331. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.03.010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"2457_CR95","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bcp.2009.07.028","volume":"79","author":"EM Garcia-Martinez","year":"2010","unstructured":"Garcia-Martinez EM, Sanz-Blasco S, Karachitos A et al (2010) Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. Biochem Pharmacol 79(2):239\u2013250. https:\/\/doi.org\/10.1016\/j.bcp.2009.07.028","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2457_CR96","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13671-011-0001-7","volume":"1","author":"JPD Garrett","year":"2012","unstructured":"Garrett JPD, Margolis DJ (2012) Impact of long-term antibiotic use for acne on bacterial ecology and health outcomes: a review of observational studies. Curr Dermatol Rep 1(1):23\u201328. https:\/\/doi.org\/10.1007\/s13671-011-0001-7","journal-title":"Curr Dermatol Rep"},{"issue":"2","key":"2457_CR97","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","volume":"169","author":"N Garrido-Mesa","year":"2013","unstructured":"Garrido-Mesa N, Zarzuelo A, G\u00e1lvez J (2013) Minocycline: far beyond an antibiotic. Br J Pharmacol 169(2):337\u2013352. https:\/\/doi.org\/10.1111\/bph.12139","journal-title":"Br J Pharmacol"},{"key":"2457_CR98","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fpsyt.2010.00136","volume":"1","author":"CJ Garwood","year":"2010","unstructured":"Garwood CJ, Cooper JD, Hanger DP et al (2010) Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front Psychiatry 1:136. https:\/\/doi.org\/10.3389\/fpsyt.2010.00136","journal-title":"Front Psychiatry"},{"issue":"1","key":"2457_CR99","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s42003-020-0966-5","volume":"3","author":"AJ Gasparrini","year":"2020","unstructured":"Gasparrini AJ, Markley JL, Kumar H (2020) Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance. Commun Biol 3(1):241. https:\/\/doi.org\/10.1038\/s42003-020-0966-5","journal-title":"Commun Biol"},{"issue":"18","key":"2457_CR100","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.3390\/ijms20184641","volume":"20","author":"A Gautieri","year":"2019","unstructured":"Gautieri A, Beeg M, Gobbi M et al (2019) The anti-amyloidogenic action of doxycycline: a molecular dynamics study on the interaction with A\u03b242. Int J Mol Sci 20(18):4641. https:\/\/doi.org\/10.3390\/ijms20184641","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2457_CR101","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"18","author":"GBD","year":"2016","unstructured":"GBD (2016) Neurology Collaborators (2019) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"issue":"3","key":"2457_CR102","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1074\/jbc.M110.178376","volume":"286","author":"S Giorgetti","year":"2011","unstructured":"Giorgetti S, Raimondi S, Pagano K et al (2011) Effect of tetracyclines on the dynamics of formation and destructuration of \u03b22-microglobulin amyloid fibrils. J Biol Chem 286(3):2121\u20132131. https:\/\/doi.org\/10.1074\/jbc.M110.178376","journal-title":"J Biol Chem"},{"issue":"2","key":"2457_CR103","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/nbdi.2002.0538","volume":"11","author":"MG Giovannini","year":"2002","unstructured":"Giovannini MG, Scali C, Prosperi C et al (2002) \u03b2-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol Dis 11(2):257\u2013274. https:\/\/doi.org\/10.1006\/nbdi.2002.0538","journal-title":"Neurobiol Dis"},{"key":"2457_CR104","doi-asserted-by":"publisher","first-page":"41755","DOI":"10.1038\/srep41755","volume":"7","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga F, Socias S, Avila CL et al (2017) Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species. Sci Rep 7:41755. https:\/\/doi.org\/10.1038\/srep41755","journal-title":"Sci Rep"},{"issue":"1","key":"2457_CR105","doi-asserted-by":"publisher","first-page":"20258","DOI":"10.1038\/s41598-020-76927-0","volume":"10","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2020","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga F, Ploper D, Avila CL et al (2020) CMT-3 targets different \u03b1-synuclein aggregates mitigating their toxic and inflammogenic effects. Sci Rep 10(1):20258. https:\/\/doi.org\/10.1038\/s41598-020-76927-0","journal-title":"Sci Rep"},{"issue":"2","key":"2457_CR106","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1365-2133.2003.05497.x","volume":"149","author":"ML Good","year":"2003","unstructured":"Good ML, Hussey DL (2003) Minocycline: stain devil? Brit J Dermatol 149(2):237\u2013239. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05497.x","journal-title":"Brit J Dermatol"},{"issue":"12","key":"2457_CR107","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","volume":"6","author":"PH Gordon","year":"2007","unstructured":"Gordon PH, Moore DH, Miller RG et al (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6(12):1045\u20131053. https:\/\/doi.org\/10.1016\/S1474-4422(07)70270-3","journal-title":"Lancet Neurol"},{"issue":"3","key":"2457_CR108","doi-asserted-by":"publisher","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","volume":"299","author":"MO Griffin","year":"2010","unstructured":"Griffin MO, Fricovsky E, Ceballos G et al (2010) tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299(3):C539\u2013C548. https:\/\/doi.org\/10.1152\/ajpcell.00047.2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"2457_CR109","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025387","volume":"6","author":"TH Grossman","year":"2016","unstructured":"Grossman TH (2016) Tetracycline antibiotics and resistance. Cold Spring Harb Perspect Med 6(4):a025387. https:\/\/doi.org\/10.1101\/cshperspect.a025387","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2457_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/jom.v4i0.19227","volume":"4","author":"Y Gu","year":"2012","unstructured":"Gu Y, Walker C, Ryan ME et al (2012) Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine. J Oral Microbiol 4:1\u201314. https:\/\/doi.org\/10.3402\/jom.v4i0.19227","journal-title":"J Oral Microbiol"},{"issue":"11","key":"2457_CR111","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neurol.2015.07.011","volume":"171","author":"P Gubellini","year":"2015","unstructured":"Gubellini P, Kachidian P (2015) Animal models of Parkinson\u2019s disease: an updated overview. Rev Neurol (paris) 171(11):750\u2013761. https:\/\/doi.org\/10.1016\/j.neurol.2015.07.011","journal-title":"Rev Neurol (paris)"},{"issue":"3","key":"2457_CR112","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41582-019-0307-9","volume":"16","author":"E Gyengesi","year":"2020","unstructured":"Gyengesi E, M\u00fcnch G (2020) In search of an anti-inflammatory drug for Alzheimer disease. Nat Rev Neurol 16(3):131\u2013132. https:\/\/doi.org\/10.1038\/s41582-019-0307-9","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2457_CR113","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells9020376","volume":"9","author":"T Hagelmaier","year":"2020","unstructured":"Hagelmaier T, Lebbing M, Duscha A et al (2020) interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson\u2019s disease. Cells 9(2):376","journal-title":"Cells"},{"issue":"2","key":"2457_CR114","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","volume":"13","author":"S Ha\u00efk","year":"2014","unstructured":"Ha\u00efk S, Marcon G, Mallet A et al (2014) Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 13(2):150\u2013158. https:\/\/doi.org\/10.1016\/S1474-4422(13)70307-7","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"2457_CR115","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","volume":"909","author":"Y He","year":"2001","unstructured":"He Y, Appel S, Le W (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909(1\u20132):187\u2013193. https:\/\/doi.org\/10.1016\/S0006-8993(01)02681-6","journal-title":"Brain Res"},{"issue":"7","key":"2457_CR116","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3390\/jcm9072042","volume":"9","author":"Y He","year":"2020","unstructured":"He Y, Li H, Sun D et al (2020) Gut microbiota: implications in Alzheimer\u2019s disease. J Clin Med 9(7):2042. https:\/\/doi.org\/10.3390\/jcm9072042","journal-title":"J Clin Med"},{"issue":"19","key":"2457_CR117","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","volume":"80","author":"LE Hebert","year":"2013","unstructured":"Hebert LE, Weuve J, Scherr PA et al (2013) Alzheimer diease in the US (2010\u20132050) estimated using the 2010 census. Neurology 80(19):1778\u20131783","journal-title":"Neurology"},{"issue":"1","key":"2457_CR118","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mds.28075","volume":"36","author":"EC Hirsch","year":"2021","unstructured":"Hirsch EC, Standaert DG (2021) Ten unsolved questions about neuroinflammation in Parkinson\u2019s disease. Mov Disord 36(1):16\u201324. https:\/\/doi.org\/10.1002\/mds.28075","journal-title":"Mov Disord"},{"key":"2457_CR119","volume-title":"Dementia","author":"C Holmes","year":"2017","unstructured":"Holmes C (2017) Inflammation in Alzheimer\u2019s disease. In: Ames D, O\u2019Brien JT, Burns A (eds) Dementia, 5th edn. CRC Press, Boca Raton","edition":"5"},{"issue":"4","key":"2457_CR120","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3109\/10409238.2014.914151","volume":"49","author":"WM Holmes","year":"2014","unstructured":"Holmes WM, Klaips CL, Serio TR (2014) Defining the limits: protein aggregation and toxicity in vivo. Crit Rev Biochem Mol Biol 49(4):294\u2013303. https:\/\/doi.org\/10.3109\/10409238.2014.914151","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"10","key":"2457_CR121","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15(10):565\u2013581. https:\/\/doi.org\/10.1038\/s41582-019-0244-7","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2457_CR122","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamaneurol.2019.3762","volume":"77","author":"R Howard","year":"2020","unstructured":"Howard R, Zubko O, Bradley R et al (2020) Minocycline at 2 different dosages vs placebo for patients with mild alzheimer disease: a randomized clinical trial. JAMA Neurol 77(2):164\u2013174. https:\/\/doi.org\/10.1001\/jamaneurol.2019.3762","journal-title":"JAMA Neurol"},{"issue":"7\u20138","key":"2457_CR123","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s007020200082","volume":"109","author":"S Hoyer","year":"2002","unstructured":"Hoyer S (2002) The aging brain. Changes in the neuronal insulin\/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm 109(7\u20138):991\u20131002. https:\/\/doi.org\/10.1007\/s007020200082","journal-title":"J Neural Transm"},{"issue":"1\u20133","key":"2457_CR124","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","volume":"490","author":"S Hoyer","year":"2004","unstructured":"Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in alzheimer disease. Eur J Pharmacol 490(1\u20133):115\u2013125. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.049","journal-title":"Eur J Pharmacol"},{"key":"2457_CR1","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01463384 (no date). Accessed 9 Decembre 2021"},{"key":"2457_CR2","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03958708?term=antibiotics&cond=Parkinson+Disease&draw=2&rank=8 (no date). Accessed 9 December 2021"},{"key":"2457_CR3","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/record\/NCT03575195?term=antibiotics&cond=Parkinson+Disease&draw=2&rank=3 (no date). Accessed 9 December 2021"},{"key":"2457_CR125","unstructured":"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-alzheimers-drug. Accessed 9 December 2021"},{"issue":"5","key":"2457_CR126","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Zhang X, Chen WW (2016) Role of oxidative stress in Alzheimer\u2019s disease (review). Biomed Rep 4(5):519\u2013522. https:\/\/doi.org\/10.3892\/br.2016.630","journal-title":"Biomed Rep"},{"issue":"1","key":"2457_CR127","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","volume":"27","author":"LK Huang","year":"2020","unstructured":"Huang LK, Chao SP, Hu CJ (2020) Clinical trials of new drugs for Alzheimer disease. J Biomed Sci 27(1):18. https:\/\/doi.org\/10.1186\/s12929-019-0609-7","journal-title":"J Biomed Sci"},{"issue":"12","key":"2457_CR128","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1111\/j.0953-816X.2004.03439.x","volume":"19","author":"CL Hunter","year":"2004","unstructured":"Hunter CL, Quintero EM, Gilstrap L et al (2004) Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur J Neurosci 19(12):3305\u20133316. https:\/\/doi.org\/10.1111\/j.0953-816X.2004.03439.x","journal-title":"Eur J Neurosci"},{"issue":"13","key":"2457_CR129","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/mds.23236","volume":"25","author":"Huntington Study Group DOMINO Investigators","year":"2010","unstructured":"Huntington Study Group DOMINO Investigators (2010) A futility study of minocycline in Huntington\u2019s disease. Mov Disord 25(13):2219\u20132224. https:\/\/doi.org\/10.1002\/mds.23236","journal-title":"Mov Disord"},{"issue":"3","key":"2457_CR130","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232","volume":"65","author":"C Ian","year":"2001","unstructured":"Ian C, Marilyn R (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65(3):232\u2013260. https:\/\/doi.org\/10.1128\/MMBR.65.2.232","journal-title":"Microbiol Mol Biol Rev"},{"key":"2457_CR131","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fnins.2015.00503","volume":"9","author":"SA Jagmag","year":"2016","unstructured":"Jagmag SA, Tripathi N, Shukla S et al (2016) Evaluation of models of Parkinson\u2019s disease. Front Neurosci 9:503. https:\/\/doi.org\/10.3389\/fnins.2015.00503","journal-title":"Front Neurosci"},{"issue":"1","key":"2457_CR132","doi-asserted-by":"publisher","first-page":"17003","DOI":"10.1038\/s41598-021-96540-z","volume":"11","author":"EC Jenkins","year":"2021","unstructured":"Jenkins EC, O\u2019Connell MJ, Manfredi G et al (2021) Doxycycline promotes proteasome fitness in the central nervous system. Sci Rep 11(1):17003. https:\/\/doi.org\/10.1038\/s41598-021-96540-z","journal-title":"Sci Rep"},{"issue":"4","key":"2457_CR133","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.diagmicrobio.2013.10.008","volume":"78","author":"RN Jones","year":"2014","unstructured":"Jones RN, Flonta M, Gurler N et al (2014) Resistance surveillance program report for selected European nations (2011). Diagn Microbiol Infect Dis 78(4):429\u2013436. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.10.008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"476","key":"2457_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aar4289","volume":"11","author":"M Kaeberlein","year":"2019","unstructured":"Kaeberlein M, Galvan V (2019) Rapamycin and Alzheimer\u2019s disease: time for a clinical trial? Sci Transl Med 11(476):1\u20136. https:\/\/doi.org\/10.1126\/scitranslmed.aar4289","journal-title":"Sci Transl Med"},{"issue":"1","key":"2457_CR135","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai SR et al (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol 53(1):648\u2013661. https:\/\/doi.org\/10.1007\/s12035-014-9053-6","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2457_CR136","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1128\/aac.40.5.1104","volume":"40","author":"M Karlsson","year":"1996","unstructured":"Karlsson M, Hammers S, Nilsson-Ehle I et al (1996) Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. Antimicrob Agents Chemother 40(5):1104\u20131107. https:\/\/doi.org\/10.1128\/aac.40.5.1104","journal-title":"Antimicrob Agents Chemother"},{"key":"2457_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.104989","volume":"131","author":"TP Keerthisinghe","year":"2019","unstructured":"Keerthisinghe TP, Wang M, Zhang Y et al (2019) Low-dose tetracycline exposure alters gut bacterial metabolism and host-immune response: \u201cPersonalized\u201d effect? Environ Int 131:104989. https:\/\/doi.org\/10.1016\/j.envint.2019.104989","journal-title":"Environ Int"},{"issue":"8","key":"2457_CR138","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/cid\/cix013","volume":"64","author":"SP Keijmel","year":"2017","unstructured":"Keijmel SP, Delsing CE, Bleijenberg G et al (2017) Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure Study): a randomized controlled trial. Clin Infect Dis 64(8):998\u20131005. https:\/\/doi.org\/10.1093\/cid\/cix013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2457_CR139","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.expneurol.2010.12.010","volume":"228","author":"AF Keller","year":"2011","unstructured":"Keller AF, Gravel M, Kriz J (2011) Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp Neurol 228(1):69\u201379. https:\/\/doi.org\/10.1016\/j.expneurol.2010.12.010","journal-title":"Exp Neurol"},{"issue":"1","key":"2457_CR140","first-page":"1003","volume":"1","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj D, Thangavel R, Natteru PA et al (2016) Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine 1(1):1003","journal-title":"J Neurol Neurosurg Spine"},{"issue":"2","key":"2457_CR141","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","volume":"196","author":"HS Kim","year":"2009","unstructured":"Kim HS, Suh YH (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196(2):168\u2013179. https:\/\/doi.org\/10.1016\/j.bbr.2008.09.040","journal-title":"Behav Brain Res"},{"issue":"8","key":"2457_CR142","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.3390\/ijms21082900","volume":"21","author":"DS Kim","year":"2020","unstructured":"Kim DS, Ko BS, Ryuk JA et al (2020a) Tetragonia tetragonioides protected against memory dysfunction by elevating hippocampal amyloid-\u03b2 deposition through potentiating insulin signaling and altering gut microbiome composition. Int J Mol Sci 21(8):2900. https:\/\/doi.org\/10.3390\/ijms21082900","journal-title":"Int J Mol Sci"},{"key":"2457_CR143","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H et al (2020b) Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69:283\u2013294. https:\/\/doi.org\/10.1136\/gutjnl-2018-317431","journal-title":"Gut"},{"issue":"6","key":"2457_CR144","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000235550","volume":"22","author":"HC Korting","year":"2009","unstructured":"Korting HC, Sch\u00f6llmann C (2009) Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol 22(6):287\u2013294. https:\/\/doi.org\/10.1159\/000235550","journal-title":"Skin Pharmacol Physiol"},{"issue":"11","key":"2457_CR145","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","volume":"72","author":"GG Kovacs","year":"2019","unstructured":"Kovacs GG (2019) Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol 72(11):725\u2013735. https:\/\/doi.org\/10.1136\/jclinpath-2019-205952","journal-title":"J Clin Pathol"},{"issue":"3","key":"2457_CR146","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","volume":"94","author":"RL Kraus","year":"2005","unstructured":"Kraus RL, Pasieczny R, Lariosa-Willingham K et al (2005) Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94(3):819\u2013827. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03219.x","journal-title":"J Neurochem"},{"issue":"3","key":"2457_CR147","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","volume":"10","author":"J Kriz","year":"2002","unstructured":"Kriz J, Nguyen MD, Julien JP (2002) Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10(3):268\u2013278. https:\/\/doi.org\/10.1006\/nbdi.2002.0487","journal-title":"Neurobiol Dis"},{"issue":"6","key":"2457_CR148","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/j.1742-4658.2009.06904.x","volume":"276","author":"K Kupsch","year":"2009","unstructured":"Kupsch K, Hertel S, Kreutzmann P et al (2009) Impairment of mitochondrial function by minocycline. FEBS J 276(6):1729\u20131738. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06904.x","journal-title":"FEBS J"},{"key":"2457_CR149","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/156081a0","volume":"156","author":"P Ladewig","year":"1945","unstructured":"Ladewig P (1945) Double-refringence of the amyloid-Congo-red-complex in histological sections. Nature 156:81\u201382","journal-title":"Nature"},{"key":"2457_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105455","volume":"158","author":"G Lavigna","year":"2021","unstructured":"Lavigna G, Masone A, Bouybayoune I et al (2021) Doxycycline rescues recognition memory and circadian motor rhythmicity but does not prevent terminal disease in fatal familial insomnia mice. Neurobiol Dis 158:105455. https:\/\/doi.org\/10.1016\/j.nbd.2021.105455","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2457_CR151","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/glia.22496","volume":"61","author":"M Lazzarini","year":"2013","unstructured":"Lazzarini M, Martin S, Mitkovski M et al (2013) Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia 61(7):1084\u20131100. https:\/\/doi.org\/10.1002\/glia.22496","journal-title":"Glia"},{"issue":"4","key":"2457_CR152","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.139.4.467","volume":"139","author":"RM Levy","year":"2003","unstructured":"Levy RM, Huang EY, Roling D et al (2003) Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 139(4):467\u2013471. https:\/\/doi.org\/10.1001\/archderm.139.4.467","journal-title":"Arch Dermatol"},{"issue":"5","key":"2457_CR153","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/revneuro-2013-0040","volume":"24","author":"C Li","year":"2013","unstructured":"Li C, Yuan K, Schluesener H (2013) Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis. Rev Neurosci 24(5):553\u2013562. https:\/\/doi.org\/10.1515\/revneuro-2013-0040","journal-title":"Rev Neurosci"},{"key":"2457_CR154","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Curcio F et al (2018) Oxidative stress, aging, and diseases. Clin Interv Aging 13:757\u2013772. https:\/\/doi.org\/10.2147\/CIA.S158513","journal-title":"Clin Interv Aging"},{"key":"2457_CR155","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clineuro.2017.07.003","volume":"160","author":"H Liu","year":"2017","unstructured":"Liu H, Su W, Li S et al (2017) Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson\u2019s disease, especially on bradykinesia. Clin Neurol Neurosurg 160:101\u2013104. https:\/\/doi.org\/10.1016\/j.clineuro.2017.07.003","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"2457_CR156","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","volume":"52","author":"MB Loeb","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M et al (2004) A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease. J Am Geriatr Soc 52(3):381\u2013387. https:\/\/doi.org\/10.1111\/j.1532-5415.2004.52109.x","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2457_CR157","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1124\/jpet.118.252064","volume":"368","author":"J Lucchetti","year":"2019","unstructured":"Lucchetti J, Fracasso C, Balducci C et al (2019) Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mices. J Pharmacol Exp Ther 368(1):32\u201340. https:\/\/doi.org\/10.1124\/jpet.118.252064","journal-title":"J Pharmacol Exp Ther"},{"key":"2457_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100982","volume":"57","author":"J Luo","year":"2020","unstructured":"Luo J, Mills K, Le Cessi S et al (2020) Ageing, age-related diseases and oxidative stress: what to do next? Ageing Res Rev 57:100982. https:\/\/doi.org\/10.1016\/j.arr.2019.100982","journal-title":"Ageing Res Rev"},{"issue":"4","key":"2457_CR159","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-131661","volume":"39","author":"T Ma","year":"2014","unstructured":"Ma T (2014) GSK3 in Alzheimer\u2019s disease: mind the isoforms. J Alzheimers Dis 39(4):707\u2013710. https:\/\/doi.org\/10.3233\/JAD-131661","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2457_CR160","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/cpt1973145852","volume":"14","author":"H Macdonald","year":"1973","unstructured":"Macdonald H, Kelly RG, Allen ES et al (1973) Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther 14(5):852\u2013861. https:\/\/doi.org\/10.1002\/cpt1973145852","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2457_CR161","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/ijms20040874","volume":"20","author":"M Maciejczyk","year":"2019","unstructured":"Maciejczyk M, \u017bebrowska E, Chabowski A (2019) Insulin resistance and oxidative stress in the brain: what\u2019s new? Int J Mol Sci 20(4):874. https:\/\/doi.org\/10.3390\/ijms20040874","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2457_CR162","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2174\/1567205014666170203125942","volume":"14","author":"V Mantzavinos","year":"2017","unstructured":"Mantzavinos V, Alexiou A (2017) Biomarkers for Alzheimer\u2019s disease diagnosis. Curr Alzheimer Res 14(11):1149\u20131154. https:\/\/doi.org\/10.2174\/1567205014666170203125942","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"2457_CR163","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","volume":"141","author":"DJ Margolis","year":"2005","unstructured":"Margolis DJ, Fanelli M, Hoffstad O et al (2005) Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 141(9):1132\u20131136. https:\/\/doi.org\/10.1001\/archderm.141.9.1132","journal-title":"Arch Dermatol"},{"issue":"3","key":"2457_CR164","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2133.2007.08056.x","volume":"157","author":"DJ Margolis","year":"2007","unstructured":"Margolis DJ, Hoffstad O, Bilker W (2007) Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol 157(3):540\u2013546. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08056.x","journal-title":"Br J Dermatol"},{"issue":"12","key":"2457_CR165","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/ajg.2010.303","volume":"105","author":"DJ Margolis","year":"2010","unstructured":"Margolis DJ, Fanelli M, Hoffstad O et al (2010) Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol 105(12):2610\u20132616. https:\/\/doi.org\/10.1038\/ajg.2010.303","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2457_CR166","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/archdermatol.2011.355","volume":"148","author":"DJ Margolis","year":"2012","unstructured":"Margolis DJ, Fanelli M, Kupperman E et al (2012) Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study. Arch Dermatol 148(3):326\u2013332. https:\/\/doi.org\/10.1001\/archdermatol.2011.355","journal-title":"Arch Dermatol"},{"issue":"1","key":"2457_CR167","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","volume":"15","author":"KA Matthews","year":"2019","unstructured":"Matthews KA, Xu W, Gaglioti A et al (2019) Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u226565 years. Alzheimers Dement 15(1):17\u201324. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3063","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2457_CR168","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE et al (1988) Reactive microglia are positive for HLA-DR in the: substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"issue":"3","key":"2457_CR169","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/11204850-000000000-00000","volume":"11","author":"K McKeage","year":"2010","unstructured":"McKeage K, Deeks ED (2010) Doxycycline 40 mg capsules (30 mg immediate-release\/10 mg delayed-release beads): anti-inflammatory dose in rosacea. Am J Clin Dermatol 11(3):217\u2013222. https:\/\/doi.org\/10.2165\/11204850-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"2457_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.635760","volume":"13","author":"L Medina","year":"2021","unstructured":"Medina L, Gonz\u00e1lez-Liz\u00e1rraga F, Dominguez-Meijide A et al (2021) Doxycycline interferes with tau aggregation and reduces its neuronal toxicity. Front Aging Neurosci 13:635760. https:\/\/doi.org\/10.3389\/fnagi.2021.635760","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2457_CR171","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.diagmicrobio.2014.12.011","volume":"81","author":"RE Mendes","year":"2015","unstructured":"Mendes RE, Farrell DJ, Sader HS et al (2015) Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method. Diagn Microbiol Infect Dis 81(4):275\u2013279. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.12.011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2457_CR172","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.theriogenology.2018.03.041","volume":"114","author":"Z Merati","year":"2018","unstructured":"Merati Z, Farshad A, Farzinpour A et al (2018) Anti-apoptotic effects of minocycline on ram epididymal spermatozoa exposed to oxidative stress. Theriogenology 114:266\u2013272. https:\/\/doi.org\/10.1016\/j.theriogenology.2018.03.041","journal-title":"Theriogenology"},{"issue":"7","key":"2457_CR173","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1073\/pnas.92.7.2959","volume":"92","author":"G Merlini","year":"1995","unstructured":"Merlini G, Ascari E, Amboldi N et al (1995) Interaction of the anthracycline 4\u2019-iodo-4\u2019-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci USA 92(7):2959\u20132963. https:\/\/doi.org\/10.1073\/pnas.92.7.2959","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2457_CR174","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"G Merlini","year":"2018","unstructured":"Merlini G, Dispenzieri A, Sanchorawala V et al (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4(1):38. https:\/\/doi.org\/10.1038\/s41572-018-0034-3","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2457_CR175","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mds.27924","volume":"35","author":"TH Mertsalmi","year":"2020","unstructured":"Mertsalmi TH, Pekkonen E, Scheperjans F (2020) Antibiotic exposure and risk of Parkinson\u2019s disease in Finland: a nationwide case-control study. Mov Disord 35(3):431\u2013442. https:\/\/doi.org\/10.1002\/mds.27924","journal-title":"Mov Disord"},{"issue":"2","key":"2457_CR176","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00430-019-00651-4","volume":"209","author":"B M\u0142ynarczyk-Bonikowska","year":"2020","unstructured":"M\u0142ynarczyk-Bonikowska B, Majewska A, Malejczyk M et al (2020) Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Med Microbiol Immunol 209(2):95\u2013108. https:\/\/doi.org\/10.1007\/s00430-019-00651-4","journal-title":"Med Microbiol Immunol"},{"issue":"5","key":"2457_CR177","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/gps.3846","volume":"28","author":"DW Molloy","year":"2013","unstructured":"Molloy DW, Standish TI, Zhou Q et al (2013) A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer\u2019s disease: the DARAD trial. Int J Geriatr Psychiatry 28(5):463\u2013470. https:\/\/doi.org\/10.1002\/gps.3846","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"2457_CR178","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s1474-4422(03)00323-5","volume":"2","author":"P Montagna","year":"2003","unstructured":"Montagna P, Gambetti P, Cortelli P (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2(3):167\u2013176. https:\/\/doi.org\/10.1016\/s1474-4422(03)00323-5","journal-title":"Lancet Neurol"},{"issue":"4","key":"2457_CR179","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF00313602","volume":"87","author":"I Moroo","year":"1994","unstructured":"Moroo I, Yamada T, Makino H et al (1994) Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson\u2019s disease. Acta Neuropathol 87(4):343\u2013348. https:\/\/doi.org\/10.1007\/BF00313602","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2457_CR180","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1007\/s11033-020-05696-w","volume":"47","author":"H Mozafari","year":"2020","unstructured":"Mozafari H, Amiri S, Mehr SE et al (2020) Minocycline attenuates depressive-like behaviors in mice treated with the low dose of intracerebroventricular streptozotocin; the role of mitochondrial function and neuroinflammation. Mol Biol Rep 47(8):6143\u20136153. https:\/\/doi.org\/10.1007\/s11033-020-05696-w","journal-title":"Mol Biol Rep"},{"issue":"8","key":"2457_CR181","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinsons disease: role for cytokines. Curr Pharm Des 11(8):999\u20131016. https:\/\/doi.org\/10.2174\/1381612053381620","journal-title":"Curr Pharm Des"},{"issue":"4","key":"2457_CR182","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23(4):858\u2013883. https:\/\/doi.org\/10.1128\/CMR.00007-10","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2457_CR183","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1471-4159.2005.03520.x","volume":"96","author":"M Nikodemova","year":"2006","unstructured":"Nikodemova M, Duncan ID, Watters JJ (2006) Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and I\u03baB\u03b1 degradation in a stimulus-specific manner in microglia. J Neurochem 96(2):314\u2013323. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03520.x","journal-title":"J Neurochem"},{"issue":"5","key":"2457_CR184","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","volume":"66","author":"NINDS NET-PD Investigators","year":"2006","unstructured":"NINDS NET-PD Investigators (2006) A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 66(5):664\u2013671","journal-title":"Neurology"},{"issue":"3","key":"2457_CR185","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","volume":"31","author":"NINDS NET-PD Investigators","year":"2008","unstructured":"NINDS NET-PD Investigators (2008) A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol 31(3):141\u2013150. https:\/\/doi.org\/10.1097\/WNF.0b013e3181342f32","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"2457_CR186","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nrl.2016.02.016","volume":"32","author":"H Niu","year":"2017","unstructured":"Niu H, Alvarez-Alvarez I, Guillen-Grima F et al (2017) Prevalence and incidence of Alzheimer\u2019s disease in Europe: a meta-analysis. Neurologia SEGO 32(8):523\u2013532. https:\/\/doi.org\/10.1016\/j.nrl.2016.02.016","journal-title":"Neurologia SEGO"},{"issue":"3","key":"2457_CR187","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1096\/fj.08-113795","volume":"23","author":"W Noble","year":"2009","unstructured":"Noble W, Garwood C, Stephenson J et al (2009) Minocycline reduces the development of abnormal tau species in models of Alzheimer\u2019s disease. FASEB J 23(3):739\u2013750. https:\/\/doi.org\/10.1096\/fj.08-113795","journal-title":"FASEB J"},{"key":"2457_CR188","unstructured":"OIE (2021). Fifth OIE annual report on the use of antimicrobial agents in animals. Better understanding of the global situation. https:\/\/www.oie.int\/en\/document\/fifth-oie-annual-report-on-antimicrobial-agents-intended-for-use-in-animals\/. Accessed 9 December 2021"},{"issue":"3","key":"2457_CR189","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/187152709788680689","volume":"8","author":"D Orsucci","year":"2009","unstructured":"Orsucci D, Calsolaro V, Mancuso M et al (2009) Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol Disord Drug Targets 8(3):222\u2013231","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2457_CR190","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3233\/JAD-2010-100204","volume":"21","author":"A Parachikova","year":"2010","unstructured":"Parachikova A, Vasilevko V, Cribbs DH et al (2010) Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. J Alzheimers Dis 21(2):527\u2013542","journal-title":"J Alzheimers Dis"},{"key":"2457_CR191","first-page":"981","volume-title":"Antimicrobial therapy and Vaccines","author":"BE Perdue","year":"1999","unstructured":"Perdue BE, Standiford HC (1999) Tetracyclines. In: Yu VL, Merigan TC, Barriere SL (eds) Antimicrobial therapy and Vaccines. Williams and Wilkins, Baltimore, p 981"},{"key":"2457_CR192","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/427318","volume":"2014","author":"T Persson","year":"2014","unstructured":"Persson T, Popescu BO, Cedazo-Minguez A (2014) Oxidative stress in Alzheimer\u2019s disease: Why did antioxidant therapy fail? Oxi Med Cell Longev 2014:427318. https:\/\/doi.org\/10.1155\/2014\/427318","journal-title":"Oxi Med Cell Longev"},{"issue":"Suppl 1","key":"2457_CR193","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Rel Dis 22(Suppl 1):S119\u2013S122. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004","journal-title":"Parkinsonism Rel Dis"},{"issue":"8","key":"2457_CR194","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A, Calvani R, Coelho-Junior H et al (2020) Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration. Antioxidants (basel) 9(8):647. https:\/\/doi.org\/10.3390\/antiox9080647","journal-title":"Antioxidants (basel)"},{"issue":"12","key":"2457_CR195","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1212\/01.wnl.0000221672.01272.ba","volume":"66","author":"M Pierantozzi","year":"2006","unstructured":"Pierantozzi M, Pietroiusti A, Brusa L et al (2006) Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations. Neurology 66(12):1824\u20131829. https:\/\/doi.org\/10.1212\/01.wnl.0000221672.01272.ba","journal-title":"Neurology"},{"issue":"2","key":"2457_CR196","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4193\/Rhino15.291","volume":"55","author":"AC Pinto Bezerra Soter","year":"2017","unstructured":"Pinto Bezerra Soter AC, Bezerra TF, Pezato R et al (2017) Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps. Rhinology 55(2):175\u2013180","journal-title":"Rhinology"},{"key":"2457_CR197","doi-asserted-by":"publisher","first-page":"9348651","DOI":"10.1155\/2016\/9348651","volume":"2016","author":"S Piras","year":"2016","unstructured":"Piras S, Furfaro AL, Domenicotti C et al (2016) RAGE Expression and ROS generation in neurons: differentiation versus damage. Oxid Med Cell Longev 2016:9348651. https:\/\/doi.org\/10.1155\/2016\/9348651","journal-title":"Oxid Med Cell Longev"},{"key":"2457_CR198","unstructured":"Prince M (2015) World Alzheimer report. Available at: https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2015.pdf"},{"issue":"13","key":"2457_CR199","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A et al (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 29(13):1583\u20131590. https:\/\/doi.org\/10.1002\/mds.25945","journal-title":"Mov Disord"},{"key":"2457_CR200","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0092-8674(00)81163-0","volume":"93","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB, Scott MR, De Armond SJ et al (1998) Prion protein biology. Cell 93:337\u2013348. https:\/\/doi.org\/10.1016\/S0092-8674(00)81163-0","journal-title":"Cell"},{"issue":"12","key":"2457_CR201","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EMM Quigley","year":"2017","unstructured":"Quigley EMM (2017) Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 17(12):94. https:\/\/doi.org\/10.1007\/s11910-017-0802-6","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"2457_CR202","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainres.2006.03.104","volume":"1093","author":"EM Quintero","year":"2006","unstructured":"Quintero EM, Willis L, Singleton R et al (2006) Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson\u2019s disease. Brain Res 1093(1):198\u2013207. https:\/\/doi.org\/10.1016\/j.brainres.2006.03.104","journal-title":"Brain Res"},{"key":"2457_CR203","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/295976","volume":"2011","author":"VS Rao","year":"2011","unstructured":"Rao VS, Nagaraj RK, Hebbagodi S et al (2011) Association of inflammatory and oxidative stress markers with metabolic syndrome in Asian Indians in India. Cardiol Res Pract 2011:295976. https:\/\/doi.org\/10.4061\/2011\/295976","journal-title":"Cardiol Res Pract"},{"issue":"4","key":"2457_CR204","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/367622","volume":"36","author":"MC Roberts","year":"2003","unstructured":"Roberts MC (2003) Tetracycline therapy: update. Clin Infec Dis 36(4):462\u2013467. https:\/\/doi.org\/10.1086\/367622","journal-title":"Clin Infec Dis"},{"issue":"7","key":"2457_CR205","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1128\/aac.42.7.1702","volume":"42","author":"JI Ross","year":"1998","unstructured":"Ross JI, Eady EA, Cove JH et al (1998) 16S rRNA mutation associated with tetracycline resistance in a gram- positive bacterium. Antimicrob Agents Chemother 42(7):1702\u20131705. https:\/\/doi.org\/10.1128\/aac.42.7.1702","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2457_CR206","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469-1480.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"issue":"4","key":"2457_CR207","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","volume":"29","author":"FV Santa-Cec\u00edlia","year":"2016","unstructured":"Santa-Cec\u00edlia FV, Socias B, Ouidja MO et al (2016) Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotox Res 29(4):447\u2013459. https:\/\/doi.org\/10.1007\/s12640-015-9592-2","journal-title":"Neurotox Res"},{"issue":"4","key":"2457_CR208","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","volume":"35","author":"FV Santa-Cec\u00edlia","year":"2019","unstructured":"Santa-Cec\u00edlia FV, Leite CA, Del-Bel E et al (2019) The neuroprotective effect of doxycycline on neurodegenerative diseases. Neurotox Res 35(4):981\u2013986. https:\/\/doi.org\/10.1007\/s12640-019-00015-z","journal-title":"Neurotox Res"},{"issue":"2","key":"2457_CR209","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"AN Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54(2):258\u2013265. https:\/\/doi.org\/10.1016\/j.jaad.2005.10.004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2457_CR210","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D et al (1990) Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 54(3):823\u2013827. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb02325.x","journal-title":"J Neurochem"},{"issue":"3","key":"2457_CR211","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000018387","volume":"200","author":"RG Schlienger","year":"2003","unstructured":"Schlienger RG, Bircher AJ, Meier CR (2003) Minocycline-induced lupus. A systematic review. Dermatology 200(3):223\u2013231","journal-title":"Dermatology"},{"issue":"4","key":"2457_CR212","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2125.2010.03733.x","volume":"70","author":"WM Schoonen","year":"2010","unstructured":"Schoonen WM, Thomas SL, Somers EC et al (2010) Do selected drugs increase the risk of lupus? A matched case-control study. Br J Clin Pharmacol 70(4):588\u2013596. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03733.x","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"2457_CR213","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/glia.20338","volume":"53","author":"TJ Seabrook","year":"2006","unstructured":"Seabrook TJ, Jiang L, Maier M et al (2006) Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53(7):776\u2013782","journal-title":"Glia"},{"issue":"8","key":"2457_CR214","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L et al (2019) Oxidative stress: A key modulator in neurodegenerative diseases. Molecules 24(8):1583. https:\/\/doi.org\/10.3390\/molecules24081583","journal-title":"Molecules"},{"key":"2457_CR215","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fnins.2014.00315","volume":"8","author":"G Singhal","year":"2014","unstructured":"Singhal G, Jaehne EJ, Corrigan F et al (2014) Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci 8:315. https:\/\/doi.org\/10.3389\/fnins.2014.00315","journal-title":"Front Neurosci"},{"key":"2457_CR216","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2012.09.036","volume":"56","author":"M Sinha","year":"2013","unstructured":"Sinha M, Bhowmick P, Banerjee A et al (2013) Antioxidant role of amyloid \u03b2 protein in cell-free and biological systems: Implication for the pathogenesis of Alzheimer disease. Free Radic Biol Med 56:184\u2013192. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.09.036","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"2457_CR217","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1582-4934.2012.01585.x","volume":"16","author":"A Skoumalov\u00e1","year":"2012","unstructured":"Skoumalov\u00e1 A, Hort J (2012) Blood markers of oxidative stress in Alzheimer\u2019s disease. J Cell Mol Med 16(10):291\u20132300. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01585.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2457_CR218","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ana.10614","volume":"54","author":"DL Smith","year":"2003","unstructured":"Smith DL, Woodman B, Mahal A et al (2003) Minocycline and doxycycline are not beneficial in a model of Huntington\u2019s disease. Ann Neurol 54(2):186\u2013196. https:\/\/doi.org\/10.1002\/ana.10614","journal-title":"Ann Neurol"},{"key":"2457_CR219","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2017.12.002","volume":"162","author":"SB Socias","year":"2018","unstructured":"Socias SB, Gonz\u00e1lez-Liz\u00e1rraga F, Avila CL (2018) Exploiting the therapeutic potential of ready-to-use drugs: repurposing antibiotics against amyloid aggregation in neurodegenerative diseases. Prog Neurobiol 162:17\u201336. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.12.002","journal-title":"Prog Neurobiol"},{"issue":"4","key":"2457_CR220","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/CMR.5.4.387","volume":"5","author":"BS Speer","year":"1992","unstructured":"Speer BS, Shoemaker NB, Salyers AA (1992) Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev 5(4):387\u2013399. https:\/\/doi.org\/10.1128\/CMR.5.4.387","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2457_CR221","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes? J Alzheimers Dis 7(1):63\u201380. https:\/\/doi.org\/10.3233\/JAD-2005-7107","journal-title":"J Alzheimers Dis"},{"issue":"15","key":"2457_CR222","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1021\/jm400161p","volume":"56","author":"T Stoilova","year":"2013","unstructured":"Stoilova T, Colombo L, Forloni G et al (2013) A new face for old antibiotics: tetracyclines in treatment of amyloidoses. J Med Chem 56(15):5987\u20136006. https:\/\/doi.org\/10.1021\/jm400161p","journal-title":"J Med Chem"},{"issue":"2","key":"2457_CR223","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/BJ20150404","volume":"470","author":"C Stretton","year":"2015","unstructured":"Stretton C, Hoffmann TM, Munson MJ et al (2015) GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling. Biochem J 470(2):207\u2013221. https:\/\/doi.org\/10.1042\/BJ20150404","journal-title":"Biochem J"},{"issue":"5","key":"2457_CR224","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/archinte.159.5.493","volume":"159","author":"MC Sturkenboom","year":"1999","unstructured":"Sturkenboom MC, Meier CR, Jick H et al (1999) Minocycline and lupus like syndrome in acne patients. Arch Int Med 159(5):493\u2013497. https:\/\/doi.org\/10.1001\/archinte.159.5.493","journal-title":"Arch Int Med"},{"key":"2457_CR225","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res Rev 45:53\u201361. https:\/\/doi.org\/10.1016\/j.arr.2018.04.004","journal-title":"Ageing Res Rev"},{"key":"2457_CR226","doi-asserted-by":"publisher","first-page":"6843265","DOI":"10.1155\/2019\/6843265","volume":"2019","author":"C Sun","year":"2019","unstructured":"Sun C, Wang Y, Mo M et al (2019) Minocycline protects against rotenone-induced neurotoxicity correlating with upregulation of Nurr1 in a Parkinson\u2019s disease rat model. Biomed Res Int 2019:6843265. https:\/\/doi.org\/10.1155\/2019\/6843265","journal-title":"Biomed Res Int"},{"issue":"SUPPL 2","key":"2457_CR227","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J Alzheimers Dis 20(SUPPL 2):265\u2013279. https:\/\/doi.org\/10.3233\/JAD-2010-100339","journal-title":"J Alzheimers Dis"},{"issue":"37","key":"2457_CR228","doi-asserted-by":"publisher","first-page":"32617","DOI":"10.1074\/jbc.M111.259572","volume":"286","author":"MD Szeto","year":"2011","unstructured":"Szeto MD, Boissel SJS, Baker D et al (2011) Mining endonuclease cleavage determinants in genomic sequence data. J Biol Chem 286(37):32617\u201332627. https:\/\/doi.org\/10.1074\/jbc.M111.259572","journal-title":"J Biol Chem"},{"issue":"5315","key":"2457_CR229","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1126\/science.276.5315.1119","volume":"276","author":"F Tagliavini","year":"1997","unstructured":"Tagliavini F, McArthur RA, Canciani B et al (1997) Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276(5315):1119\u20131122. https:\/\/doi.org\/10.1126\/science.276.5315.1119","journal-title":"Science"},{"issue":"5","key":"2457_CR230","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","volume":"300","author":"F Tagliavini","year":"2000","unstructured":"Tagliavini F, Forloni G, Colombo L et al (2000) Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol 300(5):1309\u20131322. https:\/\/doi.org\/10.1006\/jmbi.2000.3840","journal-title":"J Mol Biol"},{"issue":"3","key":"2457_CR231","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0304-3940(96)12357-0","volume":"204","author":"M Takahashi","year":"1996","unstructured":"Takahashi M, Yamada T, Tooyama I et al (1996) Insulin receptor mRNA in the substantia nigra in Parkinson\u2019s disease. Neurosci Lett 204(3):201\u2013204. https:\/\/doi.org\/10.1016\/0304-3940(96)12357-0","journal-title":"Neurosci Lett"},{"issue":"3","key":"2457_CR232","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","volume":"21","author":"AH Tan","year":"2015","unstructured":"Tan AH, Mahadeva S, Marras C et al (2015) Helicobacter pylori infection is associated with worse severity of Parkinson\u2019s disease. Parkinsonism Relat Dis 21(3):221\u2013225. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.12.009","journal-title":"Parkinsonism Relat Dis"},{"issue":"12","key":"2457_CR233","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.3390\/ijms19123824","volume":"19","author":"A Tarafdar","year":"2018","unstructured":"Tarafdar A, Pula G (2018) The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int J Mol Sci 19(12):3824. https:\/\/doi.org\/10.3390\/ijms19123824","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2457_CR234","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/jnnp.2006.104695","volume":"78","author":"KSM Taylor","year":"2007","unstructured":"Taylor KSM, Cook JA, Counsell CE (2007) Heterogeneity in male to female risk for Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78(8):905\u2013906. https:\/\/doi.org\/10.1136\/jnnp.2006.104695","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2457_CR235","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50069","volume":"8","author":"E Teo","year":"2019","unstructured":"Teo E, Ravi S, Barardo D et al (2019) Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta. Elife 8:e50069. https:\/\/doi.org\/10.7554\/eLife.50069","journal-title":"Elife"},{"issue":"3","key":"2457_CR236","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00018-009-0172-6","volume":"67","author":"M Thaker","year":"2010","unstructured":"Thaker M, Spanogiannopoulos P, Wright GD (2010) The tetracycline resistome. Cell Mol Life Sci 67(3):419\u2013431. https:\/\/doi.org\/10.1007\/s00018-009-0172-6","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"2457_CR237","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/08959374980120011601","volume":"12","author":"JG Thomas","year":"1998","unstructured":"Thomas JG, Metheny RJ, Karakiozis JM et al (1998) Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics. Adv Dent Res 12(2):32\u201339. https:\/\/doi.org\/10.1177\/08959374980120011601","journal-title":"Adv Dent Res"},{"issue":"6","key":"2457_CR238","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/1521654032000114320","volume":"55","author":"K Tieu","year":"2003","unstructured":"Tieu K, Ischiropoulos H, Przedborski S (2003) Nitric oxide and reactive oxygen species in Parkinson\u2019s disease. IUBMB Life 55(6):329\u2013335. https:\/\/doi.org\/10.1080\/1521654032000114320","journal-title":"IUBMB Life"},{"issue":"8","key":"2457_CR239","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1523\/jneurosci.21-08-02580.2001","volume":"21","author":"T Tikka","year":"2001","unstructured":"Tikka T, Fiebich BL, Goldsteins G et al (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21(8):2580\u20132588. https:\/\/doi.org\/10.1523\/jneurosci.21-08-02580.2001","journal-title":"J Neurosci"},{"issue":"3","key":"2457_CR240","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-2009-0995.Brain","volume":"16","author":"M Tong","year":"2009","unstructured":"Tong M, Dong M, De La Monte SM (2009) Brain Insulin-like growth factor and neurotrophin resistance in parkinson\u2019s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis 16(3):585\u2013599. https:\/\/doi.org\/10.3233\/JAD-2009-0995.Brain","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2457_CR241","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 57(4):1105\u20131121. https:\/\/doi.org\/10.3233\/JAD-161088","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"2457_CR242","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1096\/fj.201900071R","volume":"33","author":"TTT Tran","year":"2019","unstructured":"Tran TTT, Corsini S, Kellingray L et al (2019) APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer\u2019s disease pathophysiology. FASEB J 33(7):8221\u20138231. https:\/\/doi.org\/10.1096\/fj.201900071R","journal-title":"FASEB J"},{"issue":"6","key":"2457_CR243","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18(6):e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"issue":"SUPPL. 1","key":"2457_CR244","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-244X-8-S1-S5","volume":"8","author":"S Tsaluchidu","year":"2008","unstructured":"Tsaluchidu S, Cocchi M, Tonello L et al (2008) Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 8(SUPPL. 1):S5. https:\/\/doi.org\/10.1186\/1471-244X-8-S1-S5","journal-title":"BMC Psychiatry"},{"issue":"1","key":"2457_CR245","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/ndt.s4048","volume":"5","author":"RJ van Marum","year":"2009","unstructured":"van Marum RJ (2009) Update on the use of memantine in Alzheimer\u2019s disease. Neuropsychiatr Dis Treat 5(1):237\u2013247. https:\/\/doi.org\/10.2147\/ndt.s4048","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"2457_CR246","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","volume":"88","author":"D Varges","year":"2017","unstructured":"Varges D, Manthey H, Heinemann U et al (2017) Doxycycline in early CJD: a double-blinded randomised phase II and observational study. J Neurol Neurosurg Psychiatry 88(2):119\u2013125. https:\/\/doi.org\/10.1136\/jnnp-2016-313541","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2457_CR247","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","volume":"10","author":"KEW Vendrik","year":"2020","unstructured":"Vendrik KEW, Ooijevaar RE, de Jong PRC et al (2020) Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol 10:98. https:\/\/doi.org\/10.3389\/fcimb.2020.00098","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2457_CR248","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S et al (2020) Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 11(1):362. https:\/\/doi.org\/10.1038\/s41467-019-14177-z","journal-title":"Nat Commun"},{"issue":"1","key":"2457_CR249","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000220836","volume":"17","author":"MS Von Wittenau","year":"1971","unstructured":"Von Wittenau MS, Twomey TM, Swindell AC (1971) The disposition of doxycycline by the rat. Chemotherapy 17(1):26\u201339","journal-title":"Chemotherapy"},{"issue":"11","key":"2457_CR250","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1600-051X.2005.00840.x","volume":"32","author":"C Walker","year":"2005","unstructured":"Walker C, Preshaw PM, Novak J et al (2005) Long-term treatment with sub-antimicrobial dose doxycycline has no antibacterial effect on intestinal flora. J Clin Periodontol 32(11):1163\u20131169. https:\/\/doi.org\/10.1111\/j.1600-051X.2005.00840.x","journal-title":"J Clin Periodontol"},{"issue":"6","key":"2457_CR251","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1074\/jbc.M310162200","volume":"279","author":"Q Wang","year":"2004","unstructured":"Wang Q, Miyakoda M, Yang W et al (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279(6):4952\u20134961. https:\/\/doi.org\/10.1074\/jbc.M310162200","journal-title":"J Biol Chem"},{"issue":"1","key":"2457_CR252","doi-asserted-by":"publisher","first-page":"14707","DOI":"10.1038\/s41598-017-14408-7","volume":"7","author":"N Wang","year":"2017","unstructured":"Wang N, Tian X, Chen Y et al (2017) Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db\/db mice. Sci Rep 7(1):14707. https:\/\/doi.org\/10.1038\/s41598-017-14408-7","journal-title":"Sci Rep"},{"issue":"14","key":"2457_CR253","doi-asserted-by":"publisher","first-page":"14232","DOI":"10.18632\/aging.103440","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang J, Qang Q, Yu R et al (2020) Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression. Aging (albany NY) 12(14):14232\u201314243. https:\/\/doi.org\/10.18632\/aging.103440","journal-title":"Aging (albany NY)"},{"key":"2457_CR254","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.1182\/blood-2011-04-351643","volume":"118","author":"JE Ward","year":"2011","unstructured":"Ward JE, Ren R, Toraldo G et al (2011) Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood 118:6610\u20136617. https:\/\/doi.org\/10.1182\/blood-2011-04-351643","journal-title":"Blood"},{"issue":"10079","key":"2457_CR255","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","volume":"389","author":"HC Williams","year":"2017","unstructured":"Williams HC, Wojnarowska F, Kirtschig G et al (2017) Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet 389(10079):1630\u20131638. https:\/\/doi.org\/10.1016\/S0140-6736(17)30560-3","journal-title":"Lancet"},{"issue":"10","key":"2457_CR256","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2217\/bmm-2017-0041","volume":"11","author":"J Wojsiat","year":"2017","unstructured":"Wojsiat J, Laskowska-Kaszub K, Mietelska-Porowska A et al (2017) Search for Alzheimer\u2019s disease biomarkers in blood cells: hypotheses-driven approach. Biomark Med 11(10):917\u2013931. https:\/\/doi.org\/10.2217\/bmm-2017-0041","journal-title":"Biomark Med"},{"issue":"5","key":"2457_CR257","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/jneurosci.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackso-Lewis V, Vila M et al (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neuroscience 22(5):1763\u20131771. https:\/\/doi.org\/10.1523\/jneurosci.22-05-01763.2002","journal-title":"J Neuroscience"},{"key":"2457_CR258","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biochi.2020.04.012","volume":"174","author":"J Xu","year":"2020","unstructured":"Xu J, Zhao C, Huang X et al (2020) Tetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide. Biochimie 174:95\u2013106. https:\/\/doi.org\/10.1016\/j.biochi.2020.04.012","journal-title":"Biochimie"},{"issue":"2","key":"2457_CR259","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jnr.10709","volume":"74","author":"L Yang","year":"2003","unstructured":"Yang L, Sugama S, Chirichigno JW et al (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74(2):278\u2013285. https:\/\/doi.org\/10.1002\/jnr.10709","journal-title":"J Neurosci Res"},{"key":"2457_CR260","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L et al (2018) The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3 \u03b2 signaling in Parkinson\u2019s disease dementia. Front Neurosci 12:73. https:\/\/doi.org\/10.3389\/fnins.2018.00073","journal-title":"Front Neurosci"},{"issue":"1","key":"2457_CR261","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord 6(1):19\u201333. https:\/\/doi.org\/10.1177\/1756285612461679","journal-title":"Ther Adv Neurol Disord"},{"key":"2457_CR262","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bcp.2016.10.005","volume":"133","author":"C Y\u0131lmaz","year":"2017","unstructured":"Y\u0131lmaz C, \u00d6zcengiz G (2017) Antibiotics: pharmacokinetics, toxicity, resistance and multidrug efflux pumps. Biochem Pharmacol 133:43\u201362. https:\/\/doi.org\/10.1016\/j.bcp.2016.10.005","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2457_CR263","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1128\/AAC.28.2.347","volume":"28","author":"CW Yim","year":"1985","unstructured":"Yim CW, Flynn NM, Fitzgerald FT (1985) Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent of neurosyphilis. Antimicrob Agents Chemother 28(2):347\u2013348. https:\/\/doi.org\/10.1128\/AAC.28.2.347","journal-title":"Antimicrob Agents Chemother"},{"key":"2457_CR264","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnins.2019.00236","volume":"13","author":"EM Yimer","year":"2019","unstructured":"Yimer EM, Hishe HZ, Tuem KB (2019) Repurposing of the \u03b2-lactam antibiotic, ceftriaxone for neurological disorders: a review. Front Neurosci 13:236. https:\/\/doi.org\/10.3389\/fnins.2019.00236","journal-title":"Front Neurosci"},{"key":"2457_CR265","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","volume":"100","author":"F Yin","year":"2016","unstructured":"Yin F, Sancheti H, Patil I et al (2016) Energy metabolism and inflammation in brain aging and Alzheimer\u2019s disease. Free Radic Biol Med 100:108\u2013122. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.04.200","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"2457_CR266","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","volume":"2","author":"VW Yong","year":"2001","unstructured":"Yong VW, Power C, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2(7):502\u2013511. https:\/\/doi.org\/10.1038\/35081571","journal-title":"Nat Rev Neurosci"},{"issue":"6247","key":"2457_CR267","doi-asserted-by":"publisher","first-page":"1261669","DOI":"10.1126\/science.1261669","volume":"349","author":"KW Yoon","year":"2015","unstructured":"Yoon KW, Byun S, Kwon E et al (2015) Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science 349(6247):1261669. https:\/\/doi.org\/10.1126\/science.1261669","journal-title":"Science"},{"issue":"23","key":"2457_CR268","doi-asserted-by":"publisher","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","volume":"96","author":"J Yrj\u00e4nheikki","year":"1999","unstructured":"Yrj\u00e4nheikki J, Tikka T, Kein\u00e4nen R et al (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96(23):13496\u201313500. https:\/\/doi.org\/10.1073\/pnas.96.23.13496","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2457_CR269","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/pcn.12637","volume":"72","author":"B Yulug","year":"2018","unstructured":"Yulug B, Hanoglu L, Ozansoy M et al (2018) Therapeutic role of rifampicin in Alzheimer\u2019s disease. Psychiatry Clin Neurosci 72(3):152\u2013159. https:\/\/doi.org\/10.1111\/pcn.12637","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"2457_CR270","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/00003495-200464010-00005","volume":"64","author":"GG Zhanel","year":"2004","unstructured":"Zhanel GG, Homenuik K, Nichol K et al (2004) The glycylcyclines: a comparative review with the tetracyclines. Drugs 64(1):63\u201388. https:\/\/doi.org\/10.2165\/00003495-200464010-00005","journal-title":"Drugs"},{"issue":"6","key":"2457_CR271","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/1055-9965.EPI-07-2817","volume":"17","author":"H Zhang","year":"2008","unstructured":"Zhang H, Garc\u00eda Rodr\u00edguez LA, Hern\u00e1ndez-D\u00edaz S (2008) Antibiotic use and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 17(6):1308\u20131315. https:\/\/doi.org\/10.1158\/1055-9965.EPI-07-2817","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2457_CR272","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","volume":"50","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang J, Wang R (2018) Gut microbiota modulates drug pharmacokinetics. Drug Metab Rev 50(3):357\u2013368. https:\/\/doi.org\/10.1080\/03602532.2018.1497647","journal-title":"Drug Metab Rev"},{"issue":"4","key":"2457_CR273","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang ZQ, Shen LL, Li WW et al (2018) Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis 63(4):1337\u20131346. https:\/\/doi.org\/10.3233\/JAD-180176","journal-title":"J Alzheimers Dis"},{"key":"2457_CR274","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1742-2094-9-47","volume":"9","author":"N Zilka","year":"2012","unstructured":"Zilka N, Kazmerova Z, Jadhav S et al (2012) Who fans the flames of Alzheimer\u2019s disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation 9:47. https:\/\/doi.org\/10.1186\/1742-2094-9-47","journal-title":"J Neuroinflammation"},{"issue":"16","key":"2457_CR275","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","volume":"293","author":"MC Zink","year":"2011","unstructured":"Zink MC, Uhrlaub J, De Witt J et al (2011) Neuroprotective and Anti-Human Immunodeficiency Virus Activity of Minocycline. JAMA 293(16):2003\u20132011. https:\/\/doi.org\/10.1001\/jama.293.16.2003","journal-title":"JAMA"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-021-02457-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T13:11:31Z","timestamp":1654953091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-021-02457-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":275,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2457"],"URL":"https:\/\/doi.org\/10.1007\/s00702-021-02457-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}